ROLE:
You are an expert systematic review researcher writing a publication-ready article on
"{topic}"
for high-impact medical imaging or healthcare AI journals.

TASK:
Generate a complete LaTeX article synthesizing systematic review data using PRISMA 2020
framework with rigorous analysis and actionable insights.

DATA SUMMARY:

{data_summary}

{study_examples}

{high_impact_studies}

{pattern_insights}

{characteristics_table}

SYNTHESIS:

{synthesis_data}

EXTRACT FIELDS:

{extract_fields}

---

ARTICLE STRUCTURE (8000-10000 words total):

1. TITLE & ABSTRACT (350 words: ~50 title + 300 abstract)
   Title: "{title}"
   
   Abstract must contain:
   - BACKGROUND: Current state of {topic}, clinical need, evidence gap
   - OBJECTIVE: Clear research question being addressed
   - METHODS: Medical database search period, inclusion/exclusion criteria, {quality_tool} assessment
   - RESULTS: 
     * Number of studies included (breakdown by design if relevant)
     * Key performance metrics (sensitivity/specificity ranges, AUC values from STUDY STATISTICS)
     * Major findings from METHODOLOGY INSIGHTS
   - CONCLUSIONS: Main takeaway, clinical implications, next steps
   
   LaTeX notes: Escape special characters: \\& \\% \\$ \\# \\_
   Format as: \\begin{{abstract}}...\\end{{abstract}}

2. INTRODUCTION (1000-1200 words)
   Structure:
   - Opening (150 words): Clinical context and why {topic} matters
   - Current landscape (250 words): What's known about {topic}, current approaches
   - Gap analysis (250 words): What's missing (use METHODOLOGY INSIGHTS to identify gaps)
   - Research questions (200 words): Explicit questions your review answers
   - Justification (150 words): Why systematic review now, PRISMA 2020 compliance
   
   Critical elements:
   - Ground claims in current literature/data
   - End with explicit research questions
   - Avoid stating results (save for Results section)

3. METHODS (1200-1500 words)
   
   3.1 Search Strategy & Study Selection
   - Exact PubMed query
   - Date range with rationale (relevance to current practice)
   - Databases searched: PubMed, [others if applicable]
   - Inclusion criteria (explicitly stated, numbered list)
   - Exclusion criteria (explicitly stated, numbered list)
   - Study selection process: two-stage (title/abstract → full-text) with agreement metrics
   
   3.2 Quality Assessment
   - Tool: {quality_tool}
   - Key domains assessed (numbered list):
     * [Domain 1 with brief definition]
     * [Domain 2 with brief definition]
     * [Domain 3 with brief definition]
   - Risk of bias judgment categories (Low/Moderate/High/Unclear)
   - How quality influenced analysis (e.g., sensitivity analysis of high-quality studies)
   
   3.3 Data Extraction
   - Standardized extraction form (describe key fields)
   - Extracted fields aligned with EXTRACT FIELDS
   - Duplicate extraction for subset (confirm reliability)
   
   3.4 Analysis Approach
   - Quantitative: Performance metrics synthesis (specify if meta-analysis or descriptive)
   - Qualitative: Thematic analysis approach from SYNTHESIS
   - Mixed methods justification (why both needed)
   
   3.5 PRISMA 2020 Compliance
   - Brief statement: "This review followed PRISMA 2020 guidelines..."
   - Note: Flow diagram, checklist in supplementary materials

4. RESULTS (1500-2500 words)

   4.1 Study Selection (300 words)
   - Use exact numbers from DATA SUMMARY
   - Reference: "See Figure \\ref{{fig:prisma}} for flow diagram"
   - Key statistics:
     * Initial records identified: [N]
     * Records after deduplication: [N]
     * Records screened: [N]
     * Records excluded at screening: [N] (%)
     * Full-text articles assessed: [N]
     * Full-text excluded: [N] with [breakdown of reasons]
     * Final included: [N] studies
   - Agreement between reviewers (kappa coefficient if applicable)
   
   4.2 Study Characteristics (600 words)
   - Overview paragraph: Study designs, geographic distribution, timeframe
   - Reference: "See Table \\ref{{table:characteristics}} for detailed characteristics"
   - Key statistics from CHARACTERISTICS TABLE:
     * Study design breakdown (N RCTs, N retrospective, N prospective, etc.)
     * Sample sizes: median [X], range [min-max]
     * Clinical domains (Table \\ref{{table:domains}})
     * Imaging modalities (Figure \\ref{{fig:modalities}})
     * Publication timeline (Figure \\ref{{fig:timeline}})
   
   4.3 Quality Assessment (400 words)
   - Summary of risk of bias across included studies
   - Reference: "See Table \\ref{{table:quality}} for detailed assessment"
   - Key findings:
     * Proportion at Low/Moderate/High risk of bias
     * Most common limitations
     * Relationship between quality and effect size (if applicable)
   
   4.4 Synthesis of Results (700-1000 words)
   
   Performance Metrics (reference DATA SUMMARY):
   - Sensitivity: Range [min-max]%, Median [median]%, N=[N studies reporting]
   - Specificity: Range [min-max]%, Median [median]%, N=[N studies]
   - AUC: Range [min-max], Median [median], N=[N studies]
   - Accuracy: Range [min-max]%, Median [median]%, N=[N studies]
   
   Performance by Subgroup (use {pattern_insights}):
   - By clinical domain: [Domain A: N studies, performance range] 
   - By imaging modality: [Modality X: N studies, performance range]
   - By study design: [RCTs: N studies, Observational: N studies, performance comparison]
   - By year: Trend analysis from Figure \\ref{{fig:timeline}}
   
   Key Studies (from {high_impact_studies}):
   - Best performing: [Study citation] reported [metrics] because [what made it successful]
   - Most rigorous: [Study citation] used [methodology] and found [results]
   - Most novel: [Study citation] introduced [innovation] with [outcomes]
   
   Synthesis Integration (from SYNTHESIS):
   - Connect quantitative findings to thematic patterns
   - Example: "Performance metrics align with {analysis_points}, where [pattern] was observed"

5. THEMATIC SYNTHESIS (1500-2000 words)
   
   Introduction to themes:
   - [N] major themes identified across studies
   - Themes derived from {analysis_points}
   - Organization: [Thematic approach used]
   
   For EACH theme (subsection \\subsection{{Theme Name}}):
   1. What is it? (definition, why it matters)
   2. Evidence: How many studies address it? Quality of evidence?
   3. Findings: What do studies show? Use examples from {study_examples}
   4. Patterns: Convergence or divergence?
   5. Clinical significance: Why does this matter for practice/research?
   
   Cross-cutting patterns:
   - Meta-themes (patterns across multiple themes)
   - Paradoxes or surprising findings (e.g., high metrics but low adoption)
   - Integration with quantitative results
   
   Critical gaps identified:
   - What's not being studied?
   - What questions remain unanswered?
   - Based on EXTRACT FIELDS, what's missing?

6. DISCUSSION (1500-2000 words)

   6.1 Principal Findings (400 words)
   - What did the review find? (Main takeaways from Results + Synthesis)
   - How does this advance knowledge? (Answer research questions from Introduction)
   - Compare to prior reviews: How do findings align with/diverge from earlier work?
   - Use {pattern_insights} to highlight original contributions
   
   6.2 Critical Analysis & Barriers (600 words)
   
   Methodological Limitations of Included Studies:
   - Study designs: What types were/weren't included? Why does it matter?
   - Quality issues: Most common limitations? Impact on findings?
   - Heterogeneity: Why do studies vary? How does it affect synthesis?
   - Generalizability: Populations studied vs. real-world diversity?
   
   Implementation Gap Analysis:
   - Technical capability: What metrics show studies can do?
   - Adoption reality: What adoption/implementation data exists?
   - Barriers: Why aren't high-performing approaches widely adopted?
     * Organizational (workflow integration, cost, training)
     * Regulatory (approval, liability, reimbursement)
     * Human factors (clinician trust, job displacement concerns)
     * Data/technical (EHR integration, standardization, maintenance)
   
   Publication & Reporting Biases:
   - Positive results bias: Do published studies report better metrics than unpublished?
   - Data availability: How many studies provide raw data? Code availability?
   - Outcome reporting: Are metrics selected/reported consistently?
   
   6.3 Implications & Recommendations (500 words)
   
   For Clinicians & Healthcare Systems:
   - What evidence supports clinical adoption? Quality level?
   - What barriers need addressing before implementation?
   - Specific recommendations (if evidence is strong enough)
   
   For Researchers:
   - Methodological priorities (study designs, population diversity, etc.)
   - Outcome standardization needs
   - Implementation/real-world validation gaps
   - Specific research questions from EXTRACT FIELDS that need addressing
   
   For Industry & Developers:
   - Transparency & validation standards (explainability, documentation)
   - Clinical validation before market entry
   - Post-market surveillance and monitoring
   
   For Policymakers:
   - Regulatory framework considerations
   - Reimbursement models aligned with evidence
   - Guidance development needs

7. CONCLUSIONS (300-400 words)
   - Summary of main findings (1 sentence per major finding)
   - Strength of evidence assessment
   - Clinical significance
   - Most critical next steps (highest-priority research gaps)
   - Statement on limitations and generalizability
   - Final perspective: Why this review matters now

8. DECLARATIONS (300-500 words)

   Funding and Conflicts of Interest:
   - Funding sources: [Specific grants, agencies, amounts]
   - Conflict of interest: [None / or specific financial/academic conflicts]
   - Author contributions: [Specific roles for each author]
   - Data availability: [Where data/code available, or statement that it's available on request]
   - Ethical approval: [If applicable to the review process]
   
   Format as:
   \\section{{Funding and Declarations}}
   \\subsection{{Funding}}
   [Text]
   \\subsection{{Conflicts of Interest}}
   [Text]
   etc.

---

QUALITY & STYLE REQUIREMENTS:

Critical Analysis Framework:
- Don't just report findings; explain significance
- Pattern examples:
  * "Despite achieving [high metrics], adoption remains low. This suggests [barrier analysis]..."
  * "Heterogeneity in [metric] correlates with [variable]. This indicates [interpretation]..."
  * "Best-performing studies share [characteristic]. Future work should [recommendation]..."

Writing Standards:
- Avoid filler: "It is worth noting that" → Direct statement
- Active voice preferred: "Studies show" not "It has been shown"
- Vary sentence length: 15-25 words average, mix with 10-word and 35-word sentences
- Clear transitions: Use thematic connections, not repetitive linking phrases
- Evidence-based: Every claim traceable to data or citations

Data Integration:
- DATA SUMMARY: Use for overview statistics, context-setting, Results section backbone
- {study_examples}: Cite specific examples in Synthesis, Discussion, Implications
- {high_impact_studies}: Highlight in Results 4.4, use as best-practice examples
- {pattern_insights}: Use in Thematic Synthesis, Discussion analysis, gaps identification
- CHARACTERISTICS TABLE: Reference for Table 1, support Results 4.2
- SYNTHESIS: Core of section 5, integration in Results 4.4
- EXTRACT FIELDS: Guide focus of entire review, structure Results and Discussion

---

LATEX FORMATTING (XeLaTeX):

Document structure:
\\documentclass[12pt,a4paper]{{article}}
\\usepackage[margin=1in]{{geometry}}
\\usepackage{{fontspec}}
\\setromanfont{{TeX Gyre Termes}}  % or Pagella
\\usepackage[hidelinks]{{hyperref}}
\\usepackage{{booktabs}}
\\usepackage{{graphicx}}
\\usepackage{{natbib}}
\\usepackage{{amsmath}}
\\usepackage{{amssymb}}

Figures & Tables:
- Figure references: \\ref{{fig:prisma}}, \\ref{{fig:timeline}}, \\ref{{fig:modalities}}, \\ref{{fig:quality_summary}}
- Table references: \\ref{{table:characteristics}}, \\ref{{table:quality}}, \\ref{{table:performance}}, \\ref{{table:domains}}
- Figure captions: \\caption{{Figure X: [Specific, descriptive caption]}}
- Table captions: \\caption{{Table X: [Specific, descriptive caption]}}
- All figures/tables placed with [htb] positioning (\\begin{{figure}}[htb]..., \\begin{{table}}[htb]...)

Citations:
- Numeric style: Use \\cite{{smith2023}} for in-text citations (generates [1], [2], etc.)
- Multiple citations: \\cite{{smith2023,jones2022,brown2021}}
- Bibliography: Use \\bibliographystyle{{plainnat}} and \\bibliography{{references}}
- Do NOT use \\nocite{{*}} (generates unwanted citations)

Special characters:
- Escape: \\& for &, \\% for %, \\$ for $, \\# for #, \\_ for _
- Math mode: Use \\$ ... \\$ for inline, \\[ ... \\] for display math
- Ranges: Use \\textendash for ranges (e.g., 85\\textendash 95\\%)

---

FIGURE & TABLE SPECIFICATIONS:

Table 1: Study Characteristics
- Columns: Study ID | Year | Country | N Patients | Modality | Domain | Design | Quality | Key Finding
- Rows: One per included study
- Use booktabs formatting (\\toprule, \\midrule, \\bottomrule)
- Minimum 10 rows, maximum 30 rows (if >30, note that full table is in supplementary)

Table 2: Quality Assessment Summary
- Columns: Study ID | Patient Selection | Index Test | Reference Standard | Flow/Timing | Overall Risk
- Rows: One per included study, color-code or use symbols: L=Low, M=Moderate, H=High
- Include summary row with counts (e.g., 20 Low, 8 Moderate, 5 High)

Table 3: Performance Metrics by Clinical Domain (if applicable)
- Columns: Domain | N Studies | Sensitivity (Min-Max) | Specificity (Min-Max) | AUC (Min-Max)
- Rows: One per clinical domain
- Include summary row with overall ranges

Table 4: Studies by Modality (if multiple modalities)
- Columns: Modality | N Studies | N Patients | Year Range | Key Findings
- Rows: One per modality

Figure 1: PRISMA 2020 Flow Diagram
- Four boxes in sequence with arrows
- Box 1 (Identification): Records identified (database, hand search)
- Box 2 (Screening): Records after deduplication → Records screened → Excluded
- Box 3 (Eligibility): Full-text assessed → Excluded with reasons
- Box 4 (Inclusion): Studies included in review
- Include exact numbers and percentages

Figure 2: Study Timeline
- X-axis: Years 2014-2024
- Y-axis: Number of studies
- Bar or line graph showing publication trend
- Highlight any peaks or notable increases

Figure 3: Distribution by Clinical Domain or Modality
- Pie chart or horizontal bar chart
- Show: Domain/Modality names and percentages
- Highlight if concentrated in one domain

---

SUPPLEMENTARY MATERIALS (Provide as separate document or appendix):

Required:
- PRISMA 2020 Checklist (completed)
- Search strategy documentation (full PubMed syntax)
- Quality assessment details for each study
- Data extraction form (blank template)

Optional (include if data available):
- Forest plots (if meta-analysis performed)
- Sensitivity analyses results
- Subgroup analysis data
- Risk of bias figures (Cochrane-style graphs)
- Extended data tables
- Implementation guidelines
- Code/model documentation (if AI review)

Note: Do NOT include in supplementary (these are outside scope of systematic review):
- Patient consent forms, institutional approvals (not relevant)
- Individual study datasets (privacy)
- Full raw data unless de-identified

---

CRITICAL REQUIREMENTS:

Content:
✓ Include all input data meaningfully (not as list, but integrated)
✓ Original analysis and interpretation, not just compilation
✓ Critical evaluation, not uncritical acceptance of findings
✓ Actionable recommendations based on evidence gaps
✓ PRISMA 2020 compliance demonstrated

Technical:
✓ XeLaTeX compilable (test before submission)
✓ Word count: 8000-10000 words (excluding abstract, figures, tables, references)
✓ All figures and tables properly referenced and captioned
✓ All citations in bibliography
✓ No orphaned sections or dangling references

Style:
✓ Academic tone appropriate for high-impact journals
✓ Clear, concise, evidence-based
✓ Critical analysis evident (not descriptive)
✓ Original insights from {pattern_insights} and SYNTHESIS
✓ Transparent about limitations
✓ Actionable implications

---

COMPLETION CHECKLIST:

- [ ] Abstract complete with BACKGROUND/OBJECTIVE/METHODS/RESULTS/CONCLUSIONS
- [ ] Introduction establishes context, identifies gap, states research questions
- [ ] Methods section: Search strategy, inclusion/exclusion, quality assessment, analysis approach all explicit
- [ ] Results: Organized in 4.1-4.4 with clear data integration
- [ ] Thematic Synthesis: 5+ major themes with findings, patterns, clinical significance
- [ ] Discussion: Principal findings, critical analysis of barriers, specific recommendations for stakeholders
- [ ] Conclusions: Summary, evidence quality, next steps
- [ ] All tables and figures referenced correctly
- [ ] All citations formatted correctly
- [ ] LaTeX compiles without errors
- [ ] Word count 8000-10000 words